Evercore has torched competitors with the best returns on Wall Street over the past 10 years. Now it's setting its sights on Goldman Sachs and JPMorgan.

Posted On // Leave a Comment
Since Ralph Schlosstein joined 10 years ago, the independent investment bank Evercore has had a nearly 600% total return and massively grown its deal fees.
May 14, 2019   |   View Online »
 
Evercore has torched competitors with the best returns on Wall Street over the past 10 years. Now it's setting its sights on Goldman Sachs and JPMorgan.

Evercore has torched competitors with the best returns on Wall Street over the past 10 years. Now it's setting its sights on Goldman Sachs and JPMorgan.

Alex Morrell | Since Ralph Schlosstein joined 10 years ago, the independent investment bank Evercore has had a nearly 600% total return and massively grown its deal fees.

Read More »
JPMorgan has tapped buzzy startup Snowflake to help it solve one of the biggest issues firms face when moving to the cloud

JPMorgan has tapped buzzy startup Snowflake to help it solve one of the biggest issues firms face when moving to the cloud

Dan DeFrancesco | JPMorgan is teaming up with the red-hot startup to help the bank work across multiple public cloud providers.

Read More »
PIMCO's CEO highlights 4 tech areas he's boosting and what keeps him up at night

PIMCO's CEO highlights 4 tech areas he's boosting and what keeps him up at night

Meghan Morris | PIMCO is investing in a number of technology areas, but CEO Manny Roman said he's always worried about staying a step ahead of new competitors.

Read More »
A $1.2 billion asset manager that's quietly built one of the largest portfolios in the cannabis space is now raising a pure-play fund to chase down deals in the booming sector

A $1.2 billion asset manager that's quietly built one of the largest portfolios in the cannabis space is now raising a pure-play fund to chase down deals in the booming sector

Jeremy Berke | JW Asset Management has quietly become one of the largest investors in the cannabis industry. It's now raising a pure-play cannabis fund.

Read More »
Stalled out: Why the rush of IPOs from big, unprofitable companies like Uber and Lyft could throw the entire market off track

Stalled out: Why the rush of IPOs from big, unprofitable companies like Uber and Lyft could throw the entire market off track

Marley Jay | With the Uber and Lyft IPOs getting rough receptions, Michael Arone of State Street says other unicorns may struggle, spelling trouble for stocks.

Read More »
BANK OF AMERICA: Buy these 14 stocks, which will surge even as the US hurtles toward a full-blown trade war with China

BANK OF AMERICA: Buy these 14 stocks, which will surge even as the US hurtles toward a full-blown trade war with China

Akin Oyedele | Bank of America Merrill Lynch has screened the best stocks to own if a full-blown trade war leads to a global recession.

Read More »
Investors have seen triple-digit returns on some 2019 IPOs, but UBS think there are 2 key reasons it could cool by midsummer

Investors have seen triple-digit returns on some 2019 IPOs, but UBS think there are 2 key reasons it could cool by midsummer

Becky Peterson | Beyond Meat saw a 163% pop on its first day of trading. Here's why some analysts are waiting until mid-summer to declare the market an IPO bubble.

Read More »
Amazon built its $26 billion cloud with developers, but Microsoft is spending big bucks and changing its game to woo developers to its camp

Amazon built its $26 billion cloud with developers, but Microsoft is spending big bucks and changing its game to woo developers to its camp

Rosalie Chan | Experts say Microsoft is taking on Amazon Web Services in the cloud wars by attracting more developers through GitHub, Linux, and open source.

Read More »
A massive lawsuit just erased $2.5 billion from drug giant Teva's market cap. Here's how much Teva and rival drugmaker Mylan could stand to lose in court.

A massive lawsuit just erased $2.5 billion from drug giant Teva's market cap. Here's how much Teva and rival drugmaker Mylan could stand to lose in court.

Emma Court | Two major generic drugmakers named in this lawsuit and another, similar one could face billion-dollar fines, according to analysts at UBS.

Read More »
These are the slides about Slack's spending, sales and customer growth that the CFO is betting its IPO on

These are the slides about Slack's spending, sales and customer growth that the CFO is betting its IPO on

Becky Peterson | Slack Chief Financial Officer Allen Shim gave a presentation to analysts on Monday ahead of the company's planned direct listing IPO.

Read More »

Share This Email

  

Read Business Insider On The Go

App Store    Google Play



Email sent to: nguyenvu1187.love5@blogger.com

Manage your email preferences   |   Unsubscribe

Terms of Service   |   Privacy Policy

Business Insider. 150 Fifth Ave, New York, NY 10011
Powered By SailthrU

0 comments:

Post a Comment